Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $53.2 Million. The most recent transaction as insider was on May 12, 2022, when has been sold 5,000 shares (Common Stock) at a price of $10.9 per share, resulting in proceeds of $54,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M
0.06% 3M change
8.33% 12M change
Total Value Held $53.2 Million

Stephen Hoge Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2022
BUY
Exercise of conversion of derivative security
$54,500 $10.9 p/Share
5,000 Added 0.31%
1,627,820 Common Stock
May 10 2022
SELL
Open market or private sale
$31,288 $133.71 p/Share
234 Reduced 0.01%
1,622,820 Common Stock
May 09 2022
BUY
Exercise of conversion of derivative security
$70,157 $134.4 p/Share
522 Added 0.03%
1,623,054 Common Stock
May 03 2022
SELL
Open market or private sale
$1,419,300 $141.93 p/Share
10,000 Reduced 0.61%
1,622,532 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,632,532 Common Stock
May 02 2022
SELL
Open market or private sale
$1,348,700 $134.87 p/Share
10,000 Reduced 0.61%
1,622,532 Common Stock
May 02 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,632,532 Common Stock
Apr 25 2022
SELL
Open market or private sale
$2,921,600 $146.08 p/Share
20,000 Reduced 1.22%
1,622,532 Common Stock
Apr 25 2022
BUY
Exercise of conversion of derivative security
$152,000 $7.6 p/Share
20,000 Added 1.2%
1,642,532 Common Stock
Apr 13 2022
SELL
Open market or private sale
$2,375,550 $158.37 p/Share
15,000 Reduced 0.92%
1,622,532 Common Stock
Apr 13 2022
BUY
Exercise of conversion of derivative security
$89,250 $5.95 p/Share
15,000 Added 0.91%
1,637,532 Common Stock
Apr 12 2022
SELL
Open market or private sale
$795,000 $159.0 p/Share
5,000 Reduced 0.31%
1,622,532 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
$54,500 $10.9 p/Share
5,000 Added 0.31%
1,627,532 Common Stock
Apr 04 2022
SELL
Open market or private sale
$3,545,400 $177.27 p/Share
20,000 Reduced 1.22%
1,622,532 Common Stock
Apr 04 2022
BUY
Exercise of conversion of derivative security
$19,800 $0.99 p/Share
20,000 Added 1.2%
1,642,532 Common Stock
Mar 24 2022
SELL
Open market or private sale
$877,600 $175.52 p/Share
5,000 Reduced 0.31%
1,622,532 Common Stock
Mar 24 2022
BUY
Exercise of conversion of derivative security
$54,500 $10.9 p/Share
5,000 Added 0.31%
1,627,532 Common Stock
Mar 23 2022
SELL
Open market or private sale
$2,719,650 $181.31 p/Share
15,000 Reduced 0.92%
1,622,532 Common Stock
Mar 23 2022
BUY
Exercise of conversion of derivative security
$89,250 $5.95 p/Share
15,000 Added 0.91%
1,637,532 Common Stock
Mar 18 2022
SELL
Open market or private sale
$1,294,563 $171.67 p/Share
7,541 Reduced 0.46%
1,622,532 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$2,917,945 $151.33 p/Share
19,282 Added 1.17%
1,630,073 Common Stock
Mar 14 2022
SELL
Open market or private sale
$2,805,200 $140.26 p/Share
20,000 Reduced 1.23%
1,610,791 Common Stock
Mar 14 2022
BUY
Exercise of conversion of derivative security
$152,000 $7.6 p/Share
20,000 Added 1.21%
1,630,791 Common Stock
Mar 03 2022
SELL
Open market or private sale
$1,479,000 $147.9 p/Share
10,000 Reduced 0.62%
1,610,791 Common Stock
Mar 03 2022
BUY
Exercise of conversion of derivative security
$9,900 $0.99 p/Share
10,000 Added 0.61%
1,620,791 Common Stock

Also insider at

AXLA
Axcella Health Inc. Healthcare
Stephen Hoge

Stephen Hoge

President
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA